Wugen to Present New Clinical Data for WU-CART-007 and
-- Oral Presentation Highlights Latest Clinical Findings from First Global, In-Human Phase 1/2 Dose-Escalation Study of Anti-CD7 Off-the-Shelf Allogeneic...
Stay updated with breaking news from Metafora Biosystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Oral Presentation Highlights Latest Clinical Findings from First Global, In-Human Phase 1/2 Dose-Escalation Study of Anti-CD7 Off-the-Shelf Allogeneic...
-- Oral Presentation Highlights Latest Clinical Findings from First Global, In-Human Phase 1/2 Dose-Escalation Study of Anti-CD7 Off-the-Shelf Allogeneic CAR-T Cell Therapy, WU-CART-007, in Hard-to-Treat T-ALL/LBL Patients
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that its Board of Directors (the “Board”) elected Elsy...
WASHINGTON, April 10, 2023 -- FTI Consulting, Inc. today announced that its Board of Directors elected Elsy Boglioli as a director of the Company effective on April 7, 2023. Ms. Boglioli joins... | April 10, 2023